Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nivolumab (opdivo) (1 trial)
propofol (diprivan) (1 trial)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Trials (2 total)
Trial APIs (2 total)